Can the nose provide a direct pathway to the brain? Aptar Pharma and Dianosic discuss their collaboration, upcoming Phase I studies, and the future potential of Nose-to-Brain drug delivery. Watch our video interview: ▶️ow.ly/JZWH50ZTLcc #AptarPharma #Dianosic #NoseToBrain

Heading to #PODD2026? Don't miss Reenal Gandhi's presentation on Oct. 29 exploring the opportunities and challenges of intranasal delivery for CNS therapeutics. Connect with #AptarPharma to discuss the future of #drugdelivery. #NasalDrugDelivery

Some highlights from three fantastic days at #CPHIMilan last week. A big thank you to everyone who stopped by, connected with our teams and made this year’s event such a great one. See you next year! #CPHIMilan #AptarPharma #DrugDelivery

Heading to #WorldVaccineCongress next week? Meet the #AptarPharma team to talk nasal vaccine delivery. And don’t miss our talk on critical considerations in nasal vaccine development, Oct. 21 at 11:15 AM. See you there! #DrugDelivery #NasalVaccines

Aptar Pharma’s LuerVax® intranasal delivery device & accompanying Spray Divider have been CE marked under the EU Medical Device Regulation (MDR). This milestone expands support for customers developing innovative intranasal vaccine products. ow.ly/jtzh50ZXPFm #NasalVaccines

How can drug manufacturers gain an earlier, more complete view of assembled-system performance? Join #AptarPharma & Stevanato Group Oct 27 for a webinar exploring a USP <382>-aligned, system-level approach. Session 1: ow.ly/HU2A50ZX0Ka Session 2: ow.ly/a4z650ZX0Kb

Congratulations to our Board director, Dr. Julie Xing, on being recognized by Fortune as one of the Most Powerful Women in Asia. We’re proud to see Julie recognized among these influential leaders and celebrate the global perspective she brings to Aptar. ow.ly/liXu50ZWRw6

Thanks to everyone who joined us at #CPHIMilan this week. It was a pleasure connecting with customers, partners & industry peers & sharing how #AptarPharma is helping advance #drugdelivery. Special thanks to our entire team for making this year's event such a success. Ciao!

Earlier this week, we hosted a ribbon cutting ceremony to celebrate our expanded operations in Mumbai. The site now offers local molding and manufacturing capabilities for pMDI valves, breath-actuated systems and multidose nasal spray systems. Learn more: ow.ly/sBWf50ZW4Wn

Day 3 is underway at #CPHIMilan! Thanks to everyone who joined our talk yesterday on the future of #nasaldrugdelivery. If you are attending CPHI today, visit Booth 11A43 to meet the #AptarPharma team to learn how we support customers from formulation to patient. #DrugDelivery

Today on #WorldSightDay, we recognize the importance of accessible eye care for all. At #AptarPharma, we're committed to advancing eye health through patient-focused innovation & reliable #drugdelivery solutions. Because every person's sight matters. #Eyecare

At #PDAPFS visit Booth 411 to discover #AptarPharma’s newly launched Premia™ Precision, a new quality standard for injectables & how Noble combines human factors, training, onboarding & engagement to help turn innovative #drugdelivery systems into better patient experiences.

Day 2 at #CPHIMilan is well underway! Meet our team at Booth 11A43 to find out why customers choose to partner with #AptarPharma. And don’t miss our talk at 14:15 today at area 11A49, discussing how patient needs are shaping the evolution of #nasaldrugdelivery. #DrugDelivery

It’s Day 1 of #CPHIMilan! Make your way to #AptarPharma Booth 11A43, Hall 11 to meet our team. Explore our full range of #drugdelivery solutions & find out how we can support your journey, from formulation to patient. Looking forward to welcoming you over the next three days!

Aptar Pharma announces the launch of Premia™ Precision, a new quality standard for elastomer components designed to support sensitive, high-value injectable therapies. Read full Press Release: ow.ly/y5iI50ZUpBW #AptarPharma #PremiaPrecision #Injectables #CPHIMilan #PDAPFS

Beyond the spray itself: patient experience matters. Our latest PMPS article explores how formulation, delivery technology and human factors can come together to create differentiated nasal health solutions. Read more: ow.ly/2gqX50ZTOt9 #NasalDrugDelivery #PatientCentricity

At #PDAPFS next week, #AptarPharma will contribute to the scientific program with two posters, including one showcasing our system-level integration approach developed in collaboration with NIPRO PharmaPackaging. See you there! #InjectableDrugDelivery #PreFilledSyringes

The signal is getting stronger. Our Injectables business is revealing something new at CPHI Milan and PDA PFS next week. Stay tuned! #AptarPharma #Injectables #CPHIMilan #PDAPFS

From formulation & product protection to manufacturing readiness & commercial experience, this blog explores the considerations shaping today's two-dose nasal delivery strategies & the lessons learned through Aptar Pharma's commercial BiDose™ experience. ow.ly/ynwL50ZSvJ5

Used in 600+ products globally, #AptarPharma's Ophthalmic Squeeze Dispenser (OSD) combines #preservativefree multidose dispensing with documented test methods & worldwide regulatory support. Discover a platform trusted across #eyecare applications. #PFMD #CPHIMilan